News & Trade Shows

News & Trade shows


EZ Detect -- July 7, 2005
7/7/2005
 

BIOMERICA ANNOUNCES COMPLETION OF A COMMUNITY COLORECTAL SCREENING CAMPAIGN IN FORT WAYNE


Newport Beach, California, July 7, 2005 – Biomerica, Inc. (OTCBB: BMRA) announced today the successful conclusion of a 17,897 participant colorectal screening campaign in Fort Wayne, Indiana.

The three week campaign was conducted in cooperation with Fort Wayne’s WPTA, Channel 21, an ABC Network affiliate, Meijer Pharmacy, and Parkview Regional Cancer Center.  The aim of the campaign was to educate the public about colorectal cancer and to encourage television viewers to pick up a colorectal screening kit at a local Meijer Pharmacy.

Biomerica’s EZ Detect™ Stool Blood Test, which detects hidden blood in the stool (an early warning sign of colorectal cancer) was distributed in the campaign.  Parkview Regional Cancer Center maintained the colorectal cancer information telephone line and assisted in the education and awareness campaign.  Meijer pharmacies in the Fort Wayne area including Angola and Defiance, Ohio distributed nearly 18,000 EZ Detect™ kits to customers. Professional Health Care Associates (PHCA) organized and coordinated the campaign.

Every year, more than 50,000 Americans die from colorectal cancer, the nation’s second leading cause of cancer death.  Tragically, many die needlessly since colorectal cancer has a 90 percent cure rate when detected in its early stages.  Only 37 percent of all colorectal cancers are detected at an early stage, however, because too few people regularly screen for it.  The American Cancer Society recommends that all persons over age 50, or those with a family history of colorectal problems, perform a stool blood test at least once a year.

“It is important to increase public awareness about the benefits of screening for colorectal disease, an important prevention tool that saves lives,” said Mark Fisher, Director of Marketing of Biomerica Diagnostics.  “Biomerica intends to assist communities in conducting similar community screening programs this year and in the future.”

Biomerica’s proprietary screening product EZ detect™ is the simplest home test available to detect occult (hidden) blood in the stool, an early warning sign of colorectal cancer.  The product is sanitary, requiring no stool handling, and has no dietary restrictions.  The EZ Detect™ pad is dropped into the toilet after a bowel movement, and if blood is present in the stool, the pad will turn a blue-green color within two minutes.  Blood in stool may be caused by irritated polyps that have formed in the colon.  The blood disperses onto the surface of the toilet water, where it is detected by the EZ Detect™ pad. If a positive result occurs, a physician appointment should be schedule as soon as possible.  Blood in the stool can also signify less serious problems such as hemorrhoids, diverticulitis or bleeding ulcers but it is important to determine the exact cause.


About Biomerica (OTCBB:  BMRA)
Biomerica, Inc. (www.biomerica.com) is a global medical technology company, based in Newport Beach, CA.  Biomerica manufactures and markets advanced diagnostic products used at home, in hospitals and in physicians' offices for the early detection of medical conditions and diseases.


The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements. Certain information included in this press release (as well as information included in oral statements or other written statements made or to be made by Biomerica) contains statements that are forward-looking; such as statements relating to intended launch dates, expansion, expected orders, leading market positions, anticipated future revenues of the company, success of product and new product offerings. Such forward-looking information involves important risks and uncertainties that could significantly affect antici